Literature DB >> 34160061

British Association of Dermatologists guidelines for the management of people with vitiligo 2021.

V Eleftheriadou1, R Atkar2, J Batchelor3, B McDonald4, L Novakovic5,6, J V Patel7, J Ravenscroft8, E Rush7,9, D Shah10, R Shah11,12, L Shaw13, A R Thompson12,14, M Hashme15, L S Exton15, M F Mohd Mustapa15, L Manounah15.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34160061     DOI： 10.1111/bjd.20596

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Surgical Treatment of Vitiligo.

Authors:  Alicja Frączek; Marta Kasprowicz-Furmańczyk; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

2.  Fraxinol Stimulates Melanogenesis in B16F10 Mouse Melanoma Cells through CREB/MITF Signaling.

Authors:  Sun Young Moon; Kazi-Marjahan Akter; Mi-Jeong Ahn; Kwang Dong Kim; Jiyun Yoo; Joon-Hee Lee; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.411

3.  Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.

Authors:  Paul Leighton; Joanne R Chalmers; Jonathan M Batchelor; Andy Rogers; Perways Akram; Rachel H Haines; Garry D Meakin; Jennifer White; Jane C Ravenscroft; Tracey H Sach; Miriam Santer; Maxine E Whitton; Viktoria Eleftheriadou; Kim S Thomas
Journal:  Clin Exp Dermatol       Date:  2022-05-30       Impact factor: 4.481

4.  Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS).

Authors:  N van Geel; L Depaepe; V Vandaele; L Mertens; J Van Causenbroeck; S De Schepper; L Van Coile; A Van Reempts; A-S De Vos; J Papeleu; I Hoorens; D Mertens; A Wolkerstorfer; J E Lommerts; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-04-29       Impact factor: 9.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.